Literature DB >> 12036852

Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation.

James J Biagi1, John F Seymour.   

Abstract

Incidence rates of follicular lymphoma (FL) inexplicably vary markedly between Western and Asian countries. A hallmark of FL is the bcl-2 translocation, characterized by 1 of 2 common breakpoints known as major breakpoint region (MBR) and minor cluster region (mcr). We analyzed previously published data to compare rates of bcl-2 translocation in FL across geographic regions. Available data from the literature suggest that the incidence of bcl-2 in healthy persons in the absence of FL may be as high as 50% in Western and Asian populations. However, in FL our results show that the frequency of bcl-2 positivity was significantly higher for US than for Asian populations (P <.0001). This pattern persisted for MBR and mcr subgroups. We conclude that a significant gradient exists in the bcl-2 frequency between these FL populations. We therefore suggest that the relatively low incidence of FL in Asian populations is caused not by a lower frequency of bcl-2 rearrangements in healthy populations but by distinct molecular pathways developing in different geographic regions that nonetheless culminate in FL, which is morphologically similar but molecularly distinct. Studies demonstrating differences in clinical characteristics according to the presence or absence of bcl-2 rearrangements support this concept. Thus we hypothesize that FL may in fact be a heterogeneous malignancy encompassing entities with distinct molecular pathogenesis and potentially distinct clinical manifestations. If these findings were confirmed in prospective studies, it would imply that different etiologic or genetic factors might influence the development of FL across separate regions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036852     DOI: 10.1182/blood.v99.12.4265

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

Review 1.  Clinical and molecular prognostic factors in follicular lymphoma.

Authors:  Andrew J Davies
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

2.  Genotype frequency and F ST analysis of polymorphisms in immunoregulatory genes in Chinese and Caucasian populations.

Authors:  Qing Lan; Min Shen; Dino Garcia-Rossi; Stephen Chanock; Tongzhang Zheng; Sonja I Berndt; Vinita Puri; Guilan Li; Xingzhou He; Robert Welch; Shelia H Zahm; Luoping Zhang; Yawei Zhang; Martyn Smith; Sophia S Wang; Brian C-H Chiu; Martha Linet; Richard Hayes; Nathaniel Rothman; Meredith Yeager
Journal:  Immunogenetics       Date:  2007-10-16       Impact factor: 2.846

3.  t(14;18) Translocations and risk of follicular lymphoma.

Authors:  Charles S Rabkin; Carsten Hirt; Siegfried Janz; Gottfried Dölken
Journal:  J Natl Cancer Inst Monogr       Date:  2008

Review 4.  Chromosomal translocations among the healthy human population: implications in oncogenesis.

Authors:  Mridula Nambiar; Sathees C Raghavan
Journal:  Cell Mol Life Sci       Date:  2012-09-05       Impact factor: 9.261

5.  CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases.

Authors:  Yu Li; Shimin Hu; Zhuang Zuo; Ming Hong; Pei Lin; Shaoying Li; Sergej Konoplev; Zhen Wang; Joseph D Khoury; Ken H Young; L Jeffrey Medeiros; C Cameron Yin
Journal:  Mod Pathol       Date:  2015-03-06       Impact factor: 7.842

6.  High levels of bcl-2 protein expression do not correlate with genetic abnormalities but predict worse prognosis in patients with lymphoblastic lymphoma.

Authors:  Yajun Gu; Yi Pan; Bin Meng; Bingxin Guan; Kai Fu; Baocun Sun; Fang Zheng
Journal:  Tumour Biol       Date:  2013-03-14

Review 7.  Economic burden of follicular non-Hodgkin's lymphoma.

Authors:  Talia Foster; Jeffrey D Miller; Mark E Boye; Mason W Russell
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

8.  Nodal Follicular Lymphomas: A Clinicopathological Study from a Tertiary Care Centre in South India.

Authors:  Divya Supari; Anuradha Ananthamurthy
Journal:  Indian J Hematol Blood Transfus       Date:  2015-11-02       Impact factor: 0.900

9.  Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma.

Authors:  E Paszkiewicz-Kozik; J Kulik; A Fabisiewicz; A Tysarowski; E Kraszewska; J A Siedlecki; J Walewski
Journal:  Med Oncol       Date:  2008-05-10       Impact factor: 3.064

10.  Analysis of follicular lymphoma by dual-color fluorescence in situ hybridization.

Authors:  Dakeun Lee; Jinwon Seo; YoungLyun Oh; Jinman Kim; YoungHyeh Ko
Journal:  Virchows Arch       Date:  2007-11-27       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.